Value of F-18-fluorodeoxyglucose positron emission tomography after induction therapy of locally advanced bronchogenic carcinoma

Journal of Thoracic and Cardiovascular Surgery

Volumn 128, Issue 6, 2004, Pages 892-899

  Hellwig, Dirk ^a   Graeter, Thomas P ^a   Ukena, Dieter ^a   Georg, Thomas ^a   Kirsch, Carl Martin ^a   Schäfers, Hans Joachim ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PLATINUM;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LOBECTOMY; LUNG NON SMALL CELL CANCER; MALE; MEDIASTINUM DISEASE; METASTASIS; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, BRONCHOGENIC; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; REMISSION INDUCTION; RETROSPECTIVE STUDIES;

EID: 9644273756     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2004.07.031     Document Type: Article

References (30)

1. M. Thomas, M. Baumann, M. Deppermann, L. Freitag, U. Gatzemeier, R. Huber [Recommendations on the therapy of bronchial carcinoma] Pneumologie. 56 2002 113 131
2. G. Iosilevsky, D. Front, L. Bettman, R. Hardoff, Y. Ben-Arieh Uptake of gallium-67 citrate and [2-3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy J Nucl Med. 26 1985 278 282
3. S.N. Reske, J. Kotzerke FDG-PET for clinical use Results of the 3rd German Interdisciplinary Consensus Conference, "Onko-PET III," 21 July and 19 September 2000 Eur J Nucl Med 28 2001 1707 1723
4. D. Hellwig, D. Ukena, F. Paulsen, M. Bamberg, C.M. Kirsch [Meta-analysis of the efficacy of positron emission tomography with F-18-fluorodeoxyglucose in lung tumors. Basis for discussion of the German Consensus Conference on PET in Oncology 2000] Pneumologie. 55 2001 367 377
5. H. van Tinteren, O.S. Hoekstra, E.F. Smit, J.H. van den Bergh, A.J. Schreurs, R.A. Stallaert Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial Lancet 359 2002 1388 1393
6. J.F. Vansteenkiste, S.G. Stroobants, P.J. Dupont, P.R. De Leyn, E.K. Verbeken, G.J. Deneffe Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases Leuven Lung Cancer Group J Clin Oncol 17 1999 3201 3206
7. J.S. Ryu, N.C. Choi, A.J. Fischman, T.J. Lynch, D.J. Mathisen FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology Lung Cancer 35 2002 179 187
8. T. Akhurst, R.J. Downey, M.S. Ginsberg, M. Gonen, M. Bains, R. Korst An initial experience with FDG-PET in the imaging of residual disease after induction therapy for lung cancer Ann Thorac Surg 73 2002 259 266
9. R.J. Cerfolio, B. Ojha, S. Mukherjee, A.H. Pask, C.S. Bass, C.R. Katholi Positron emission tomography scanning with 2-fluoro-2-deoxy-d-glucose as a predictor of response of neoadjuvant treatment for non-small cell carcinoma J Thorac Cardiovasc Surg 125 2003 938 944
10. N.C. Choi, A.J. Fischman, A. Niemierko, J.S. Ryu, T. Lynch, J. Wain Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in locally advanced non-small-cell lung cancer Int J Radiat Oncol Biol Phys 54 2002 1024 1035
11. J.L. Port, M.S. Kent, R.J. Korst, R. Keresztes, M.A. Levin, N.K. Altorki Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer Ann Thorac Surg 77 2004 254 259
12. J.F. Vansteenkiste, S.G. Stroobants, P.R. De Leyn, P.J. Dupont, E.K. Verbeken Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa-N2 non-small-cell lung cancer: a prospective pilot study The Leuven Lung Cancer Group Ann Oncol 9 1998 1193 1198
13. W.A. Weber, V. Petersen, B. Schmidt, L. Tyndale-Hines, T. Link, C. Peschel Positron emission tomography in non-small-cell lung cancer: prediction of response to chemotherapy by quantitative assessment of glucose use J Clin Oncol 21 2003 2651 2657
14. M.P. MacManus, R.J. Hicks, J.P. Matthews, A. McKenzie, D. Rischin, E.K. Salminen Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer J Clin Oncol 21 2003 1285 1292
15. Y. Ichiya, Y. Kuwabara, M. Sasaki, T. Yoshida, J. Omagari, Y. Akashi A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma Ann Nucl Med 10 1996 193 200
16. M. Thomas, U. Gatzemeier, R. Goerg, W. Matthiessen, H. Morr, N. Schonfeld [Recommendations on the diagnosis of bronchial carcinoma German Pneumology Society] Pneumologie. 54 2000 361 371
17. T.P. Graeter, D. Hellwig, K. Hoffmann, D. Ukena, C.M. Kirsch, H.J. Schfers Mediastinal lymph node staging in suspected lung cancer: comparison of positron emission tomography with F-18-fluorodeoxyglucose and mediastinoscopy Ann Thorac Surg 75 2003 231 236
18. C.F. Mountain, C.M. Dresler Regional lymph node classification for lung cancer staging Chest 111 1997 1718 1723
19. C.D. Ramos, Y.E. Erdi, M. Gonen, E. Riedel, H.W. Yeung, H.A. Macapinlac FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection Eur J Nucl Med 28 2001 155 164
20. H.F. Lausberg, T.P. Graeter, O. Wendler, S. Demertzis, D. Ukena, H.J. Schfers Bronchial and bronchovascular sleeve resection for treatment of central lung tumors Ann Thorac Surg 70 2000 367 372
21. A.R. Gibbs, R.L. Attanoos Examination of lung specimens J Clin Pathol 53 2000 507 512
22. C.C. Pitz, K.W. Maas, H.A. Van Swieten, A.B. de la Riviere, P. Hofman, F.M. Schramel Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer Ann Thorac Surg 74 2002 164 169
23. M.P. MacManus, R.J. Hicks, J.P. Matthews, A. Hogg, A.F. McKenzie, A. Wirth High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy Int J Radiat Oncol Biol Phys 50 2001 287 293
24. U. Nestle, D. Hellwig, J. Fleckenstein, K. Walter, D. Ukena, C. Rbe Comparison of early pulmonary changes in 18FDG-PET and CT after combined radiochemotherapy for advanced non-small-cell lung cancer: a study in 15 patients Frontiers of Radiation Therapy and Oncology W. Drr R. Engenhart-Cabillic J. Zimmermann Normal tissue reactions in radiotherapy and oncology Vol. 37 2002 Karger Basel p. 26 33
25. J.R. Roberts, C. Eustis, R. Devore, D. Carbone, H. Choy, D. Johnson Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer Ann Thorac Surg 72 2001 885 888
26. C. Doddoli, P. Thomas, X. Thirion, Y. Sere, R. Giudicelli, P. Fuentes Postoperative complications in relation with induction therapy for lung cancer Eur J Cardiothorac Surg 20 2001 385 390
27. V. Ahuja, R.E. Coleman, J. Herndon, E.F. Patz Jr The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma Cancer 83 1998 918 924
28. H.J. Jeong, J.J. Min, J.M. Park, J.K. Chung, B.T. Kim, J.M. Jeong Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer Nucl Med Commun 23 2002 865 870
29. K. Higashi, Y. Ueda, Y. Arisaka, T. Sakuma, Y. Nambu, M. Oguchi 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer J Nucl Med 43 2002 39 45
30. E.F. Patz Jr, J. Connolly, J. Herndon Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer AJR Am J Roentgenol 174 2000 769 774